Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Related Experiment Videos

[Progress in oral antibiotic therapy in practice].

H E Pichler1

  • 1Infektionsabteilung des Kaiser-Franz-Josef-Spitals, Wien, Austria.

Infection
|January 1, 1991
PubMed
Summary

New antibiotics represent progress in infectious disease management by offering improved safety, efficacy, and cost-effectiveness. Advances in oral antibiotics for common infections like respiratory and urinary tract issues are highlighted.

Related Concept Videos

You might also read

Related Articles

Articles linked to this work by shared authors, journal, and citation graph.

Sort by
Same author

Clinical efficacy of ciprofloxacin compared with placebo in bacterial diarrhea.

The American journal of medicineยท1987
See all related articles

Area of Science:

  • Pharmacology
  • Infectious Diseases
  • Microbiology

Background:

  • Antibiotic treatment safety is crucial for managing infectious diseases.
  • Progress requires new agents with enhanced antibacterial activity and improved pharmacokinetic/pharmacodynamic profiles.
  • Reduced treatment costs and better patient compliance are key indicators of advancement.

Purpose of the Study:

  • To discuss progress in infectious disease management through new antibiotic agents.
  • To evaluate advancements in oral antibiotics for common outpatient infections.
  • To highlight the significance of improved safety, efficacy, and cost-effectiveness in antibiotic therapy.

Main Methods:

  • Review of established and novel antibiotic classes.
  • Discussion of pharmacokinetic and pharmacodynamic properties.
  • Analysis of treatment outcomes for respiratory and urinary tract infections.

Main Results:

  • Newer antibiotic classes, including quinolones, amoxicillin-clavulanic acid combinations, macrolides, and cephalosporins, show promise.
  • These agents offer potential for improved antibacterial activity and patient compliance.
  • Advancements contribute to safer and more cost-effective infectious disease management.

Conclusions:

  • The introduction of novel oral antibiotics signifies substantial progress in managing common infectious diseases.
  • Improvements in safety, efficacy, and pharmacoeconomics are critical for advancing antibiotic treatment.
  • Continued research into new antimicrobial agents is essential for combating infectious diseases.

Related Experiment Videos